The Progress of Induced Pluripotent Stem Cells as Models of Parkinson’s Disease
In recent years, induced pluripotent stem cells (iPSCs) were widely used for investigating the mechanisms of Parkinson’s disease (PD). Somatic cells from patients with SNCA (α-synuclein), LRRK2 (leucine-rich repeat kinase 2), PINK1 (PTEN induced putative kinase 1), Parkin mutations, and at-risk indi...
Saved in:
| Main Authors: | Ji-feng Kang, Bei-sha Tang, Ji-feng Guo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2016/4126214 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
by: Xinchao Hu, et al.
Published: (2020-01-01) -
Parkinson’s Disease and Cognitive Impairment
by: Yang Yang, et al.
Published: (2016-01-01) -
Induced Pluripotent Stem Cells: Development in the Ophthalmologic Field
by: Nan Wu, et al.
Published: (2016-01-01) -
Technological Progress in Generation of Induced Pluripotent Stem Cells for Clinical Applications
by: Seung-Ick Oh, et al.
Published: (2012-01-01) -
Urine-Derived Induced Pluripotent Stem Cells in Cardiovascular Disease
by: Ping Huang, et al.
Published: (2020-01-01)